|
The impella device was not received from the customer, therefore, investigation of the device was not possible.Should the device or any new information be received, a supplemental mdr will be filed.Instructions for use for the related event are as follows: section: general patient care considerations ¿assess access site for bleeding and hematoma.¿ section: entering cardiac output use of the repositioning sheath and peel-away introducer ¿remove the peel-away introducer completely from the artery over the catheter shaft to prevent trauma and significant bleeding and apply manual pressure above the puncture site.¿ section: potential adverse events (united states) acute renal dysfunction, aortic valve injury, bleeding, cardiogenic shock, cerebral vascular accident/stroke, death, hemolysis, limb ischemia, myocardial infarction, renal failure, thrombocytopenia and cardiac or vascular injury (including ventricular perforation).¿ this report is being filed as part of a retrospective review of historical records.
|
|
The user facility reported a patient noted as high risk percutaneous coronary intervention was implanted with an impella ld device for mechanical circulatory support.While on support, the patient was observed to be bleeding post coronary artery bypass graft (cabg).It was stated that the patient was transfused 6 units of blood products in an effort to manage the complication.However, the patient's bleeding was persistent.It was stated that the medical staff withheld heparin until the bleeding was under control.Weaning was successful, the device was explanted, and the procedural outcome was the patient survived.
|